DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft
Authors:
- 17 September 2013
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 72 (5) , 1031-1041
Abstract
Purpose Capecitabine is one of the few chemotherapy drugs with high oral availability. Recently, sodium dichloroacetate (DCA) has shown great potential as an anticancer agent. In the present study, we assessed the anticancer effect of DCA in combination with capecitabine for cancers that modestly expressed TP. Methods A mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft were used to assess the effect of DCA and capecitabine combined treatment. Histology and immunohistochemistry were used to detect the apoptosis and proliferation of cancer cells. Real-time PCR and Western blot were carried out to detect the expression of TP and caspases, respectively. Results For the first time, we report that DCA increased the antitumor effects of capecitabine in a mouse B16 allograft and a human A549 xenograft by promoting apoptosis of tumor cells. DCA has little effect on the expression of TP. Conclusions Our finding suggests that DCA in combination with capecitabine might be potential as a new therapeutic regimen against some cancers.Keywords
This publication has 32 references indexed in Scilit:
- Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy2010
- Metabolic Modulation of Glioblastoma with DichloroacetateScience Translational Medicine, 2010
- Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7/IL-24Molecular and Cellular Biochemistry, 2010
- Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancerBritish Journal of Cancer, 2008
- PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancerBritish Journal of Cancer, 2008
- Dichloroacetate (DCA) sensitizes both wild‐type and over expressing Bcl‐2 prostate cancer cells in vitro to radiationThe Prostate, 2008
- Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era?Science's STKE, 2007
- A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer GrowthCancer Cell, 2007
- Why do cancers have high aerobic glycolysis?Nature Reviews Cancer, 2004
- THE METABOLISM OF TUMORS IN THE BODYJournal of General Physiology, 1927